市場調查報告書
商品編碼
1298887
特種學名藥市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測Specialty Generics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球特種學名藥市場規模達到674億美元。展望未來,IMARC Group預計,到2028年,市場規模將達到1254億美元,在2023-2028年期間的成長率(CAGR)為10.8%。
特種學名藥是特種藥物的仿製版本,一旦它們失去專利權。這些藥物用於治療慢性或複雜的健康狀況,包括癌症、自身免疫性疾病、癲癇、艾滋病、肝炎、多發性硬化症、類風濕性關節炎等。與其品牌版本相比,特色學名藥具有成本效益,因為它們不需要昂貴的開發和行銷成本。
與傳統學名藥相比,特殊學名藥市場更加集中,參與者較少,因為它們的生產要求複雜,資本成本較高,而且由於患者人數較少,產量相對較低。這導致與品牌藥相比,價格降低得更少,因此,與傳統學名藥相比,利潤率更高。特種學名藥需要特殊的處理、管理和監測,一般需要事先授權才能訂購。目前,全球特種學名藥市場受到幾個因素的推動,如人口老齡化加劇,一些品牌特種藥的專利到期,各種威脅生命的疾病如癌症、多發性硬化症、艾滋病等的發病率增加,醫療機構的成本控制措施,新興市場的成長等。
10.1.3.1.1 市場趨勢
10.1.3.1.2 市場預測
10.1.3.2.1 市場趨勢
10.1.3.2.2 市場預測
10.2 歐洲
10.2.3.1.1 市場趨勢
10.2.3.1.2 市場預測
10.2.3.2.1 市場趨勢
10.2.3.2.2 市場預測
10.2.3.3.1 市場趨勢
10.2.3.3.2 市場預測
10.2.3.4.1 市場趨勢
10.2.3.4.2 市場預測
10.2.3.5.1 市場趨勢
10.2.3.5.2 市場預測
10.3.3.1.1 市場趨勢
10.3.3.1.2 市場預測
10.3.3.2.1 市場趨勢
10.3.3.2.2 市場預測
10.3.3.3.1 市場趨勢
10.3.3.3.2 市場預測
10.3.3.4.1 市場趨勢
10.3.3.4.2 市場預測
10.4.3.1.1 市場趨勢
10.4.3.1.2 市場預測
10.4.3.2.1 市場趨勢
10.4.3.2.2 市場預測
The global specialty generics market size reached US$ 67.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 125.4 Billion by 2028, exhibiting a growth rate (CAGR) of 10.8% during 2023-2028.
Specialty generics are generic versions of specialty drugs, once they get off-patent. These drugs are used to treat chronic or complex health conditions including cancer, autoimmune diseases, epilepsy, HIV, Hepatitis, multiple sclerosis, rheumatoid arthritis, etc. Speciality generics are cost-effective as compared to their branded versions as they don't require costly development and marketing costs.
Compared to traditional generics, the speciality generics market is more concentrated with fewer players due to their complex manufacturing requirements, higher capital costs and relatively lower volumes as a result of smaller patient population. This results in lower price reduction compared to the branded drug and consequently higher margins compared to traditional generics. Speciality generics require special handling, administration, monitoring and generally need prior authorization to order them. The global speciality generics market is currently being driven by several factors such as rising ageing population, patent expiration of a number of branded specialty drugs, increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, HIV, etc., cost containment measures from healthcare providers, growth from emerging markets, etc.
IMARC Group provides an analysis of the key trends in each sub-segment of the global specialty generics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on route of administration, indication and distribution channel.
North America
United States
Canada
Europe
Italy
Germany
Spain
United Kingdom
France
Asia-Pacific
China
India
Japan
South Korea
Latin America
Brazil
Mexico
Middle East and Africa
Injectables
Oral
Others
Oncology
Autoimmune Diseases
Infectious Diseases
Others
Retail Pharmacies
Specialty Pharmacies
Hospital Pharmacies
The global specialty generics market consists of numerous manufacturers. Some of the leading players operating in the market are Teva Pharmaceuticals Industries, Akorn, Inc., Mylan N.V., Mallinckrodt, Sandoz International GmbH, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Valeant Pharmaceuticals, Apotex Corp., Endo International plc.
IMARC Group's latest report provides a deep insight into the global specialty generics market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the specialty generics market in any manner.
Key Questions Answered in This Report
1. What is the size of the global specialty generics market?
2. What are the key factors driving the global specialty generics market?
3. What has been the impact of COVID-19 on the global specialty generics market?
4. What is the breakup of the global specialty generics market based on the route of administration?
5. What is the breakup of the global specialty generics market based on the indication?
6. What is the breakup of the global specialty generics market based on the distribution channel?
7. What are the key regions in the global specialty generics market?
8. Who are the key players/companies in the global specialty generics market?